ABSTRACT
Introduction: Selective laser trabeculoplasty (SLT) is used successfully for management of early to advanced glaucoma and ocular hypertension (OHT). Primary open-angle glaucoma (OAG), pseudoexfoliation glaucoma (PXFG), pigmentary glaucoma, normal-tension glaucoma, primary angle-closure glaucoma, steroid-induced glaucoma, silicone oil-induced glaucoma, and high intraocular pressure after canaloplasty and trabeculectomy are the main indications.
Areas covered: A review of the literature was performed to highlight recent advances in terms of suggested mechanisms, indications, efficacy, prognostic factors, surgical technique, postoperative care, complications, repeatability, cost-effectiveness, and quality of life (QoL) implications of SLT in glaucoma patients.
Expert commentary: SLT is a safe, cost-effective, and repeatable procedure. It increases QoL, but it has not received wide application it deserves in glaucoma management. SLT may be a first-line treatment option in mild-to-moderate glaucoma. It may also be an adjuvant treatment in OHT and in all subtypes of glaucoma. SLT use may gain popularity in all types of OAGs, closed-angle glaucomas and OHT in the future.
Declaration of interest
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Reviewer Disclosures
Peer reviewers on this manuscript have no relevant financial relationships or otherwise to disclose.